MedPath
HSA Approval

ANAGRELIDE MEVON CAPSULES 0.5 MG

SIN17118P

ANAGRELIDE MEVON CAPSULES 0.5 MG

ANAGRELIDE MEVON CAPSULES 0.5 MG

October 17, 2024

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM PHARMA PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L01XX35

Manufacturer Information

NOVEM PHARMA PRIVATE LIMITED

Titan Laboratories Pvt. Ltd.

Active Ingredients

Anagrelide HCl eqv Anagrelide

0.5 mg

Anagrelide

Documents

Package Inserts

Anagrelide Mevon Capsule PI.pdf

Approved: October 17, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ANAGRELIDE MEVON CAPSULES 0.5 MG - HSA Approval | MedPath